Unexpected Death of a Duchenne Muscular Dystrophy Patient in an N-of-1 Trial of rAAV9-delivered CRISPR-transactivator

Angela Lek, Brenda Wong, Allison Keeler, Meghan Blackwood, Kaiyue Ma, Shushu Huang, Katelyn Sylvia, Ana Rita Batista, Rebecca Artinian, Danielle Kokoski, Shestruma Parajuli, Juan Putra, Chrystalle Katte Carreon, Hart Lidov, Keryn Woodman, Sander Pajusalu, Janelle M. Spinazzola, Thomas Gallagher, Joan LaRovere, Diane Baulderson, Lauren Black, Keith Sutton, Richard Horgan, Monkol Lek, Terence Flotte
doi: https://doi.org/10.1101/2023.05.16.23289881

Article Information

doi 
https://doi.org/10.1101/2023.05.16.23289881
History 
  • May 30, 2023.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Angela Lek, Ph.D.1,2,*,
  2. Brenda Wong, M.D.3,*,
  3. Allison Keeler, Ph.D.3,5,
  4. Meghan Blackwood5,
  5. Kaiyue Ma1,
  6. Shushu Huang, M.D.1,
  7. Katelyn Sylvia5,
  8. Ana Rita Batista, Ph.D.4,5,
  9. Rebecca Artinian3,5,
  10. Danielle Kokoski3,5,
  11. Shestruma Parajuli5,
  12. Juan Putra, M.D.6,
  13. Chrystalle Katte Carreon, M.D.6,
  14. Hart Lidov, M.D. Ph.D.6,
  15. Keryn Woodman, Ph.D.1,
  16. Sander Pajusalu, M.D. Ph.D.1,7,8,
  17. Janelle M. Spinazzola, Ph.D.9,
  18. Thomas Gallagher, Ph.D.5,
  19. Joan LaRovere, M.D.10,
  20. Diane Baulderson, Ph.D.11,
  21. Lauren Black, Ph.D.12,
  22. Keith Sutton, Ph.D.12,
  23. Richard Horgan13,
  24. Monkol Lek, Ph.D.1,* and
  25. Terence Flotte, M.D.3,5,*,†
  1. 1Department of Genetics, Yale School of Medicine, New Haven, CT, USA
  2. 2Muscular Dystrophy Association, Chicago, IL, USA
  3. 3Department of Pediatrics, University of Massachusetts Chan Medical School, Worcester, MA, USA
  4. 4Department of Neurology, University of Massachusetts Chan Medical School, Worcester MA, USA
  5. 5Horae Gene Therapy Center and The Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, MA, USA
  6. 6Department of Pathology, Boston Children’s Hospital and Harvard Medical School, Boston, MA, USA
  7. 7Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia
  8. 8Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia
  9. 9Division of Genetics, Boston Children’s Hospital and Harvard Medical School, Boston, MA, USA
  10. 10Department of Cardiology, Boston Children’s Hospital and Harvard Medical School, Boston, MA, USA
  11. 11Regulatory Innovation LLC, Raleigh, NC, USA
  12. 12Charles River Laboratories, Wilmington, MA, USA
  13. 13Cure Rare Disease, Woodbridge, CT, USA
  1. ↵†Corresponding author:
    Terence Flotte, email: terry.flotte{at}umassmed.edu

  1. ↵* These authors contributed equally to this work.

Back to top
Posted May 30, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Unexpected Death of a Duchenne Muscular Dystrophy Patient in an N-of-1 Trial of rAAV9-delivered CRISPR-transactivator
Angela Lek, Brenda Wong, Allison Keeler, Meghan Blackwood, Kaiyue Ma, Shushu Huang, Katelyn Sylvia, Ana Rita Batista, Rebecca Artinian, Danielle Kokoski, Shestruma Parajuli, Juan Putra, Chrystalle Katte Carreon, Hart Lidov, Keryn Woodman, Sander Pajusalu, Janelle M. Spinazzola, Thomas Gallagher, Joan LaRovere, Diane Baulderson, Lauren Black, Keith Sutton, Richard Horgan, Monkol Lek, Terence Flotte
medRxiv 2023.05.16.23289881; doi: https://doi.org/10.1101/2023.05.16.23289881
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area